Citations (37)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
Cay Laurene Goh, Jacinta Trudy Cheng, Mithu Palit, Shane Costello & David Anthony Barton. (2023) Pharmacological management of neuropsychiatric symptoms in geriatric traumatic brain injury: a scoping review. Brain Injury 37:4, pages 356-371.
Read now
Read now
George Konstantakopoulos, Stefanos Dimitrakopoulos & Panayiota G. Michalopoulou. (2020) The preclinical discovery and development of agomelatine for the treatment of depression. Expert Opinion on Drug Discovery 15:10, pages 1121-1132.
Read now
Read now
Articles from other publishers (35)
Yu-Bing Wang, Ning-Ning Song, Yu-Qiang Ding & Lei Zhang. (2023) Neural plasticity and depression treatment. IBRO Neuroscience Reports 14, pages 160-184.
Crossref
Crossref
Juan Huang, Xiao-Meng Xie, Nan Lyu, Bing-Bing Fu, Qian Zhao, Ling Zhang & Gang Wang. (2023) Agomelatine in the treatment of anhedonia, somatic symptoms, and sexual dysfunction in major depressive disorder. Frontiers in Psychiatry 14.
Crossref
Crossref
Başaran KARADEMİR. (2023) The assessment of effectiveness of a novel antidepressant, Agomelatine on anxiety and depression induced by fluoride intoxication by means of Open-Field and Hot-Plate tests in mouse model (BalB-C). Ankara Üniversitesi Veteriner Fakültesi Dergisi 70:2, pages 123-130.
Crossref
Crossref
Nevertyty M. Mahmoud, Shimaa M. Elshazly, Arwa A. Hassan & Eman Soliman. (2023) Agomelatine improves streptozotocin-induced diabetic nephropathy through melatonin receptors/SIRT1 signaling pathway. International Immunopharmacology 115, pages 109646.
Crossref
Crossref
Qiang Su, Tian Li, Guo-Wei Liu, Yan-Li Zhang, Jun-Hong Guo, Zhao-Jun Wang, Mei-Na Wu & Jin-Shun Qi. (2023) Agomelatine: a potential novel approach for the treatment of memory disorder in neurodegenerative disease. Neural Regeneration Research 18:4, pages 727.
Crossref
Crossref
Gianluca Serafini, Alessandra Costanza, Andrea Aguglia, Andrea Amerio, Alice Trabucco, Andrea Escelsior, Leo Sher & Mario Amore. (2023) The Role of Inflammation in the Pathophysiology of Depression and Suicidal Behavior. Medical Clinics of North America 107:1, pages 1-29.
Crossref
Crossref
Giacomo Gatti, Mario Giordano & Corrado Mollica. 2023. Noninvasive Mechanical Ventilation and Neuropsychiatric Disorders. Noninvasive Mechanical Ventilation and Neuropsychiatric Disorders
145
160
.
Seon-Cheol Park & Winston Wu-Dien Shen. 2020. Tasman’s Psychiatry. Tasman’s Psychiatry
1
53
.
Muhammad Naveed, Lian-Di Li, Gang Sheng, Zi-Wei Du, Ya-Ping Zhou, Sun Nan, Ming-Yi Zhu, Jing Zhang & Qi-Gang Zhou. (2022) Agomelatine: An Astounding Sui-generis Antidepressant?. Current Molecular Pharmacology 15:7, pages 943-961.
Crossref
Crossref
Matej Ľupták, Zdeněk Fišar & Jana Hroudová. (2022) Agomelatine, Ketamine and Vortioxetine Attenuate Energy Cell Metabolism—In Vitro Study. International Journal of Molecular Sciences 23:22, pages 13824.
Crossref
Crossref
Nikolaj Kjær Høier, Trine Madsen, Adam P. Spira, Keith Hawton, Poul Jennum, Merete Nordentoft & Annette Erlangsen. (2022) Associations between treatment with melatonin and suicidal behavior: a nationwide cohort study. Journal of Clinical Sleep Medicine 18:10, pages 2451-2458.
Crossref
Crossref
Hussein Bdair, Thomas A. Singleton, Karen Ross, Dean Jolly, Min Su Kang, Arturo Aliaga, Marius Tuznik, Tanpreet Kaur, Saïd Yous, Jean-Paul Soucy, Gassan Massarweh, Peter J. H. Scott, Robert Koeppe, Gilberto Spadoni, Annalida Bedini, David A. Rudko, Gabriella Gobbi, Chawki Benkelfat, Pedro Rosa-Neto, Allen F. Brooks & Alexey Kostikov. (2022)
Radiosynthesis and
In Vivo
Evaluation of Four Positron Emission Tomography Tracer Candidates for Imaging of Melatonin Receptors
. ACS Chemical Neuroscience 13:9, pages 1382-1394.
Crossref
Crossref
Xiao-bo Yang, Heng-bing Zu, Yong-fei Zhao & Kai Yao. (2022) Agomelatine Prevents Amyloid Plaque Deposition, Tau Phosphorylation, and Neuroinflammation in APP/PS1 Mice. Frontiers in Aging Neuroscience 13.
Crossref
Crossref
N.N. Petrova. (2022) New goals for depression therapy. Zhurnal nevrologii i psikhiatrii im. S.S. Korsakova 122:11, pages 57.
Crossref
Crossref
Kimberly Johnson, Meghna P. Mansukhani & Bhanu Prakash Kolla. 2022. Comprehensive Pharmacology. Comprehensive Pharmacology
149
178
.
Gerd Laux. 2022. NeuroPsychopharmacotherapy. NeuroPsychopharmacotherapy
1381
1391
.
Eunsoo Won, Kyoung-Sae Na & Yong-Ku Kim. (2021) Associations between Melatonin, Neuroinflammation, and Brain Alterations in Depression. International Journal of Molecular Sciences 23:1, pages 305.
Crossref
Crossref
Jeong Seok Seo, Won-Myong Bahk, Young Sup Woo, Young-Min Park, Won Kim, Jong-Hyun Jeong, Se-Hoon Shim, Jung Goo Lee, Seung-Ho Jang, Chan-Mo Yang, Sheng-Min Wang, Myung Hun Jung, Hyung Mo Sung, IL Han Choo, Bo-Hyun Yoon, Sang-Yeol Lee, Duk-In Jon & Kyung Joon Min. (2021) Korean Medication Algorithm for Depressive Disorder 2021, Fourth Revision: An Executive Summary. Clinical Psychopharmacology and Neuroscience 19:4, pages 751-772.
Crossref
Crossref
Shijing Wang, Francesco Leri & Sakina J. Rizvi. (2021) Anhedonia as a central factor in depression: Neural mechanisms revealed from preclinical to clinical evidence. Progress in Neuro-Psychopharmacology and Biological Psychiatry 110, pages 110289.
Crossref
Crossref
Ahmet Yardimci, Mehmet Ridvan Ozdede & Haluk Kelestimur. (2021) Agomelatine, A Potential Multi-Target Treatment Alternative for Insomnia, Depression, and Osteoporosis in Postmenopausal Women: A Hypothetical Model. Frontiers in Psychiatry 12.
Crossref
Crossref
Christine E. Mc Carthy. (2021) Sleep Disturbance, Sleep Disorders and Co-Morbidities in the Care of the Older Person. Medical Sciences 9:2, pages 31.
Crossref
Crossref
Monika Dmitrzak-Weglarz, Ewa Banach, Karolina Bilska, Beata Narozna, Aleksandra Szczepankiewicz, Edyta Reszka, Ewa Jablonska, Paweł Kapelski, Maria Skibinska & Joanna Pawlak. (2021) Molecular Regulation of the Melatonin Biosynthesis Pathway in Unipolar and Bipolar Depression. Frontiers in Pharmacology 12.
Crossref
Crossref
Roberto F. Almeida, Tiago P. Ferreira, Camila V. C. David, Paulo C. Abreu e Silva, Sulamita A. dos Santos, Ana L. S. Rodrigues & Elaine Elisabetsky. (2021) Guanine-Based Purines as an Innovative Target to Treat Major Depressive Disorder. Frontiers in Pharmacology 12.
Crossref
Crossref
Hui-Hua Li, Xiao-Yan Yao, Sheng Tao, Xue Sun, Pan-pan Li, Xi-xin Li, Zhu-Li Liu & Chao Ren. (2021) Serotonin 2 Receptors, Agomelatine, and Behavioral and Psychological Symptoms of Dementia in Alzheimer’s Disease. Behavioural Neurology 2021, pages 1-6.
Crossref
Crossref
E. P. van Poelgeest, A. C. Pronk, D. Rhebergen & N. van der Velde. (2021) Depression, antidepressants and fall risk: therapeutic dilemmas—a clinical review. European Geriatric Medicine 12:3, pages 585-596.
Crossref
Crossref
Marsal Sanches, Joao Quevedo & Jair C. Soares. (2021) New agents and perspectives in the pharmacological treatment of major depressive disorder. Progress in Neuro-Psychopharmacology and Biological Psychiatry 106, pages 110157.
Crossref
Crossref
Young-Min Park, Jeong Seok Seo, Young Sup Woo, Won-Myong Bahk, Won Kim, Jong-Hyun Jeong, Se-Hoon Shim, Jung Goo Lee, Seung-Ho Jang, Sheng-Min Wang, Myung Hun Jung, Hyung Mo Sung, IL Han Choo, Bo-Hyun Yoon, Sang-Yeol Lee, Duk-In Jon & Kyung Joon Min. (2021) Korean Medication Algorithm Project for Depressive Disorder 2021 (II): The Subtypes of Depression. Journal of Korean Neuropsychiatric Association 60:3, pages 186.
Crossref
Crossref
Matteo Preve. (2021) Could Agomelatine Play a Role to Treat Anhedonia in Heroin Dependence?. Addictive Disorders & Their Treatment 20:3, pages 211-212.
Crossref
Crossref
Trevor R. Norman. 2021. The Neuroscience of Depression. The Neuroscience of Depression
301
308
.
Gerd Laux. 2020. NeuroPsychopharmacotherapy. NeuroPsychopharmacotherapy
1
11
.
Florian Klomp, Christoph Wenzel, Marek Drozdzik & Stefan Oswald. (2020) Drug–Drug Interactions Involving Intestinal and Hepatic CYP1A Enzymes. Pharmaceutics 12:12, pages 1201.
Crossref
Crossref
Sheng-Min Wang, Young Sup Woo, Nak-Young Kim, Hae-Ran Na, Hyun Kook Lim & Won-Myong Bahk. (2020) Agomelatine for the Treatment of Generalized Anxiety Disorder: A Meta-Analysis. Clinical Psychopharmacology and Neuroscience 18:3, pages 423-433.
Crossref
Crossref
Andrew Tsotinis & Ioannis P. Papanastasiou. 2020. Melatonin - The Hormone of Darkness and its Therapeutic Potential and Perspectives. Melatonin - The Hormone of Darkness and its Therapeutic Potential and Perspectives.
Qingqing Cheng, Jihan Huang, Ling Xu, Yunfei Li, Huafang Li, Yifeng Shen, Qingshan Zheng & Lujin Li. (2020) Analysis of Time-Course, Dose-Effect, and Influencing Factors of Antidepressants in the Treatment of Acute Adult Patients With Major Depression. International Journal of Neuropsychopharmacology 23:2, pages 76-87.
Crossref
Crossref
Massimo Dal Monte, Maurizio Cammalleri, Salvatore Pezzino, Roberta Corsaro, Nicola Pescosolido, Paola Bagnoli & Dario Rusciano. (2020) Hypotensive Effect of Nanomicellar Formulation of Melatonin and Agomelatine in a Rat Model: Significance for Glaucoma Therapy. Diagnostics 10:3, pages 138.
Crossref
Crossref